期刊文献+

伏立康唑致精神症状一例 被引量:2

下载PDF
导出
摘要 患者男,85岁,体质量50 kg.因“反复右上腹隐痛2年余,全腹痛10余小时”于2013年6月8日入院.入院查体:体温37 ℃,呼吸20次/min,心率100次/min,血压120/80 mmHg(1 mmHg=0.133 kPa).神志清楚,皮肤巩膜无黄染,心肺无异常,全腹紧张,右上腹压痛(+),Murphy征(+),无反跳痛,肝脾肋下未触及,移动性浊音(-),肠鸣音3次/min.辅助检查:血白细胞计数20.2×109/L,中性粒细胞百分比94.4%,C反应蛋白31 mg/L;丙氨酸转氨酶192.0 U/L,天冬氨酸转氨酶247.0 U/L,总胆红素23.3 μmol/L,直接胆红素0.00 μmol/L,血淀粉酶3 152 U/L,尿淀粉酶11 838 U/L.
出处 《中国医药》 2015年第1期135-135,共1页 China Medicine
  • 相关文献

参考文献4

二级参考文献22

  • 1曹永兵,张磊,王彦,姜远英.伏立康唑及其临床应用[J].中国新药与临床杂志,2005,24(4):330-332. 被引量:48
  • 2刘玮,杨新良,王雪松,王俊,蔡璐,郁祁.国产伏立康唑治疗耐氟康唑念珠菌深部感染疗效观察[J].临床药物治疗杂志,2007,5(1):32-34. 被引量:7
  • 3PFALLER MA,ZHANG J,MESSER SA,et al. In vitro activities of voriconazole, ftubonazol,and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother, 1999,43 ( 1 ) : 169 - 171.
  • 4SUTTON DA, SANCHE SE, REVANKAR SG, et al. In vitro amplhoteriein B resistance in clinical isolates of Aspergillus terreus,with a head-to-head comparison to voriconazole. J ClinMicro2biol, 1999,37 (7) :2343.
  • 5DENNING DW,R IBAUD P,MILP IED N,et al. Efficacy and safety of vorieonazole in the treatment of acute invasive aspergillosis. Clin Infect Dis,2002,34(5) :563-571.
  • 6Herbrecht 1L, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.N EnglJ Med, 2002, 347 (6) : 408-415.
  • 7Vehreschild JJ, B6ohme A, Reichert D, et al. Treatment of invasive fungal infections in clinical practice : a multi-centre survey on customary dosing, treatment indications, effcacy and safeW of voriconazole. IntJ Hematol, 2008, 87 (2) : 126-131.
  • 8Lev e que D, Nivoix Y, Jehl F, , et al. Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents, 2006, 27 ( 4 ) : 274-284.
  • 9Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis, 2008, 46 ( 2 ) : 201-211.
  • 10Boyd AE, Modi S, Howard SJ, et al. Adverse reactions to voriconazole. Clin Infect Dis, 2004, 39 (8) : 1241-1244.

共引文献342

同被引文献37

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部